TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22250210

Group type: EXPERIMENTAL
Intervention: Stimulation of the common peroneal nerve to generate an afferent volley timed to arrive during specific phases of the cortical potential during motor imagination (50 repetitions).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Afferent volley arriving during the peak negative deflection of the cortical potential.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Artificially generated signal (peripheral afferent volley) interacting with physiologically generated signal during imagined movement.
Number of subjects: 0
Study: 20722556

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 32
Study: 17853277

Group type: EXPERIMENTAL
Intervention: Quetiapine 300 mg/day
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Quetiapine 600 mg/day
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Quetiapine 300 mg/day and 600 mg/day
Number of subjects: 351
Study: 16027809

Group type: EXPERIMENTAL
Intervention: Simvastatin (Zocor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preparation of polyunsaturated phospholipids (lipostabil forte)
Number of subjects: 0
Study: 12823127

Group type: EXPERIMENTAL
Intervention: Active SLIT
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 14971863

Group type: EXPERIMENTAL
Intervention: Clozapine (450 mg/day)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Olanzapine (50 mg/day)
Number of subjects: 13
Study: 10466877

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg daily for 10 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8682927

Group type: EXPERIMENTAL
Intervention: PerioGard test kit
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control subjects (healthy sites)
Number of subjects: 106
Study: 2193420

Group type: EXPERIMENTAL
Intervention: Soft ski boots
Number of subjects: 33

Group type: COMPARATOR
Intervention: Stiff ski boots
Number of subjects: 33
Study: 442014

Group type: EXPERIMENTAL
Intervention: D‐ASA (Dipyridamole 30 mg and ASA 300 mg administered intravenously two hours before surgery, then orally three times a day in tablets containing dipyridamole 50 mg and ASA 330 mg)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Low doses of Heparin (5000 IU subcutaneously twice a day starting two hours pre-operatively)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 146
Study: 28665937

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 100,000 UI/week for 3 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 26116485

Group type: EXPERIMENTAL
Intervention: Bronchoscopic lung volume reduction (endobronchial valves)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham valve placement (control)
Number of subjects: 50
Study: 23277262

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 149

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 149

Group type: COMPARATOR
Intervention: Venlafaxine
Number of subjects: 149
Study: 20932709

Group type: EXPERIMENTAL
Intervention: Computer-assisted, patient-specific navigational templates for hip resurfacing arthroplasty
Number of subjects: 0
Study: 19465372

Group type: EXPERIMENTAL
Intervention: Physical therapy interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-quality randomized controlled trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical interactions analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External validation
Number of subjects: 0
Study: 17318449

Group type: EXPERIMENTAL
Intervention: Psychological intervention (details not specified)
Number of subjects: 268
Study: 15616408

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonconventional forms of physical exercise (including yoga)
Number of subjects: 0
Study: 11710409

Group type: EXPERIMENTAL
Intervention: Sodium citrate (0.5 g x kg(-1) body mass)
Number of subjects: 9

Group type: COMPARATOR
Intervention: NaCl (0.1 g x kg(-1) body mass)
Number of subjects: 9
Study: 9205017

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg, titrated to 20 mg if needed
Number of subjects: 177

Group type: COMPARATOR
Intervention: Simvastatin 10 mg, titrated to 20 mg if needed
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 177

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 177
Study: 7963867

Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 315

Group type: COMPARATOR
Intervention: Non-operated group
Number of subjects: 315
Study: 3655863

Group type: EXPERIMENTAL
Intervention: Spinal Magnetic Resonance Imaging (MRI)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional Myelography
Number of subjects: 31
Study: 30334639

Group type: EXPERIMENTAL
Intervention: Verinurad 5 mg
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Verinurad 10 mg
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Verinurad 12.5 mg
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Verinurad 2.5 mg
Number of subjects: 375

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study: 28679683

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) at 10°C
Number of subjects: 19

Group type: COMPARATOR
Intervention: Passive room temperature control at 23°C
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Regular postexercise CWI
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: SIT (6 weeks)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Regular CWI after 6 weeks of SIT
Number of subjects: 19
Study: 26125101

Group type: EXPERIMENTAL
Intervention: Systemic methotrexate (MTX)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 64
Study: 23505198

Group type: EXPERIMENTAL
Intervention: Obese individuals classified by BMI (≥ 30 kg/m(2)) and BF% (≥ 25% for men and ≥ 35% for women) (OO)
Number of subjects: 486

Group type: COMPARATOR
Intervention: Nonobese individuals classified by BMI but obese by BF% (NOO)
Number of subjects: 486
Study: 21831359

Group type: EXPERIMENTAL
Intervention: Paliperidone ER Medium (3 mg)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Paliperidone ER Low (1.5 mg)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Paliperidone ER High (6 mg)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Paliperidone ER (3 mg)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Paliperidone ER (6 mg)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Paliperidone ER (12 mg)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 19594486

Group type: EXPERIMENTAL
Intervention: Etoricoxib or Diclofenac with reminders and free PPI
Number of subjects: 10026
Study: 17676687

Group type: EXPERIMENTAL
Intervention: CD-ROM-delivered CBT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 weekly group CBT sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control (WL)
Number of subjects: 0
Study: 14987325

Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Calcium and vitamin D alone
Number of subjects: 42
Study: 11588633

Group type: EXPERIMENTAL
Intervention: GON infiltration with bupivacaina 0.5% (BP)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Physiological serum 0.9% (PS)
Number of subjects: 37
Study: 9674375

Group type: COMPARATOR
Intervention: Running on surfaced footpath
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Running on short grass
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Running on long grass
Number of subjects: 9
Study: 8078162

Group type: EXPERIMENTAL
Intervention: Individualized developmental care by trained nurses
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 38
Study: 2491940

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 55838

Group type: EXPERIMENTAL
Intervention: high-titre HbsAb gamma-globulin
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: normal gamma-globulin
Number of subjects: 279

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 279
Study: 31944363

Group type: EXPERIMENTAL
Intervention: Unhealthy weight control behaviors (purging and nonpurging)
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Perception of being overweight
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Being overweight
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Severe depression
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: High socio-economic status
Number of subjects: 690
Study: 30293664

Group type: EXPERIMENTAL
Intervention: ranolazine
Number of subjects: 81

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 81
Study: 28991664

Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard rehabilitation treatment (control group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 26659934

Group type: EXPERIMENTAL
Intervention: Botanical anti-inflammatory acne regimen
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional benzoyl peroxide comparator
Number of subjects: 80
Study: 24003870

Group type: EXPERIMENTAL
Intervention: Excessive gestational weight gain based on the IOM recommendations
Number of subjects: 298

Group type: COMPARATOR
Intervention: Appropriate gestational weight gain based on the IOM recommendations
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Prepregnancy BMI
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 298
Study: 21869712

Group type: EXPERIMENTAL
Intervention: Triamcinolone hexacetonide (TAH) 20 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TA) 40 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) injection
Number of subjects: 30
Study: 18543492

Group type: EXPERIMENTAL
Intervention: Yiqi Yangyin Jiedu Decoction (YYJD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chemotherapy (NP or GP protocol)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: YYJD and chemotherapy in combination
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: YYJD
Number of subjects: 60
Study: 16865869

Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MAL-PDT
Number of subjects: 43
Study: 14692211

Group type: EXPERIMENTAL
Intervention: Colgate Total Advanced Fresh toothpaste (0.30% triclosan, 2% PVM/MA copolymer, 0.243% sodium fluoride)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Colgate Cavity Protection Winterfresh Gel (0.243% sodium fluoride)
Number of subjects: 81
Study: 10853878

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg orally once a day for 4 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9115000

Group type: EXPERIMENTAL
Intervention: 20 micrograms EE2 + 75 micrograms GSD
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30 micrograms EE2 + 75 micrograms GSD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 8465010

Group type: EXPERIMENTAL
Intervention: Pre‐ or postoperative megavoltage radiation therapy (45 Gy/5 weeks)
Number of subjects: 960

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Pre‐ or postoperative megavoltage radiation therapy
Number of subjects: 960
Study: 3022694

Group type: EXPERIMENTAL
Intervention: Nitrazepam
Number of subjects: 52

Group type: COMPARATOR
Intervention: Corticotropin
Number of subjects: 52
Study: 30339635

Group type: EXPERIMENTAL
Intervention: Low plasma gelsolin levels (below the 25th percentile) in medical patients
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Low plasma gelsolin levels (below the 25th percentile) in both medical and surgical patients
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Low plasma gelsolin levels
Number of subjects: 746
Study: 29563027

Group type: EXPERIMENTAL
Intervention: PARO robotic seal (15-min sessions three afternoons per week for 10 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Plush toy (PARO with robotic features disabled)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study: 26981628

Group type: EXPERIMENTAL
Intervention: Mobile Short-Message-Service-Based Disease Outbreak Alert System
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no text-messaging system)
Number of subjects: 0
Study: 25227114

Group type: EXPERIMENTAL
Intervention: Early goal-directed therapy using arterial waveform analysis
Number of subjects: 542

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 542
Study: 22662775

Group type: EXPERIMENTAL
Intervention: CO2 insufflation during ileo-colonoscopy (132 patients)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: CO2 insufflation during ileo-colonoscopy plus gastroscopy (53 patients)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Air insufflation during ileo-colonoscopy (82 patients)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Air insufflation during ileo-colonoscopy plus gastroscopy (42 patients)
Number of subjects: 309
Study: 20144066

Group type: EXPERIMENTAL
Intervention: Benidipine (4-8 mg/day) combined with olmesartan (10 mg/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Amlodipine (5-10 mg/day) combined with olmesartan (10 mg/day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both regimens (benidipine and amlodipine)
Number of subjects: 17
Study: 18042477

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 650

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 650

Group type: COMPARATOR
Intervention: TMP/SMX
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Overall fluoroquinolone susceptibility
Number of subjects: 650
Study: 15523335

Group type: EXPERIMENTAL
Intervention: Channel length of 9.0 mm
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Distance of 4.0 mm
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Varying diameters, lengths, and distances
Number of subjects: 240
Study: 11213073

Group type: EXPERIMENTAL
Intervention: 2 mg/day sirolimus
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: 5 mg/day sirolimus
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study: 9627862

Group type: EXPERIMENTAL
Intervention: Ibuprofen (800 mg 3 times a day for 1 week, 800 mg twice a day for 1 week, and 800 mg as needed to a maximum daily dose of 2400 mg for 7 weeks) and nocturnal wrist supports
Number of subjects: 91

Group type: COMPARATOR
Intervention: Chiropractic treatment (manipulation of soft tissues and bony joints of the upper extremities and spine, ultrasound over the carpal tunnel, and nocturnal wrist supports)
Number of subjects: 91
Study: 7877194

Group type: EXPERIMENTAL
Intervention: Captopril (37.5-75 mg/d)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nadolol (40-80 mg/d)
Number of subjects: 60
Study: 3048092

Group type: EXPERIMENTAL
Intervention: Cefixime (400 mg once daily)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Amoxicillin (250 or 500 mg three times daily)
Number of subjects: 560
Study: 30041105

Group type: EXPERIMENTAL
Intervention: Individualized church reports including church capacity scores and recommendations for health promotion programming.
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Meetings with church leaders to review reports.
Number of subjects: 14
Study: 28080323

Group type: EXPERIMENTAL
Intervention: 400 mg of ATP as disodium salt
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 25824543

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 0
Study: 24135085

Group type: EXPERIMENTAL
Intervention: Diabetes prevention program (DPP) consisting of an individual session followed by five group sessions at two-week intervals and two follow-up telephone calls.
Number of subjects: 574

Group type: COMPARATOR
Intervention: Usual care from general practitioners.
Number of subjects: 574
Study: 21145923

Group type: EXPERIMENTAL
Intervention: 6 second condition with unpleasant foregrounds
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 6 second condition with pleasant foregrounds
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 6 second condition for heart rate (HR)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 30 millisecond condition with pleasant foregrounds
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 30 millisecond condition with unpleasant foregrounds
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 30 millisecond condition for heart rate (HR)
Number of subjects: 36
Study: 18327678

Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study: 17163255

Group type: EXPERIMENTAL
Intervention: Paracetamol 1g plus ciprofloxacin 500mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Paracetamol 1g
Number of subjects: 10
Study: 14586376

Group type: EXPERIMENTAL
Intervention: Ovum donor in vitro fertilization
Number of subjects: 64

Group type: COMPARATOR
Intervention: Native oocyte in vitro fertilization
Number of subjects: 64

Group type: COMPARATOR
Intervention: Frozen/thawed native oocyte cycles
Number of subjects: 64
Study: 10790626

Group type: EXPERIMENTAL
Intervention: Bologna procedure
Number of subjects: 47

Group type: COMPARATOR
Intervention: Ingelman-Sundberg procedure
Number of subjects: 47
Study: 9322521

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg daily for 4 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Naltrexone and 6 beta-naltrexol levels
Number of subjects: 16
Study: 8485074

Group type: EXPERIMENTAL
Intervention: High-stress interview condition
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-stress interview condition
Number of subjects: 30
Study: 4056256

Group type: EXPERIMENTAL
Intervention: Nifedipine aerosol, 10 mg in 40% ethanol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diluent alone (control)
Number of subjects: 6
Study: 29987566

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy with ERAS (LA‐E)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Laparoscopic appendectomy with conventional care (LA‐C)
Number of subjects: 108
Study: 29923614

Group type: EXPERIMENTAL
Intervention: C1M (MMP‐generated type I collagen fragment)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: C3M (MMP‐generated type III collagen fragment)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: C4M (MMP‐generated type IV collagen fragment)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: PRO‐C3 (pro‐peptide of type III collagen)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: All collagen fragments
Number of subjects: 203
Study: 27311493

Group type: EXPERIMENTAL
Intervention: Gastric bypass
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lifestyle-medical management
Number of subjects: 120
Study: 1335388

Group type: EXPERIMENTAL
Intervention: Lower-body negative pressure at -10 mmHg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lower-body negative pressure at -15 mmHg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Head-up tilt at 30 degrees
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Head-up tilt at 60 degrees
Number of subjects: 15
Study: 22747856

Group type: EXPERIMENTAL
Intervention: Drug lymphocyte stimulation test (DLST) performed at Week 1 of adverse reactions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug lymphocyte stimulation test (DLST) performed 2 months after the reaction (Group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug lymphocyte stimulation test (DLST) performed >12 months after the reaction (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 0
Study: 19678808

Group type: EXPERIMENTAL
Intervention: Real rTMS (3 Hz)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Real rTMS (10 Hz)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 48
Study: 18768511

Group type: EXPERIMENTAL
Intervention: Folate supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MTHFR 677 TT genotype
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MTHFR 1298 CC genotype
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (wild-type alleles)
Number of subjects: 0
Study: 16277550

Group type: EXPERIMENTAL
Intervention: cisplatin-gemcitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: gemcitabine-paclitaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: cisplatin-paclitaxel
Number of subjects: 0
Study: 12456031

Group type: EXPERIMENTAL
Intervention: 6% hydroxy ethyl starch solution (10 ml/kg, 30 minutes)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: FPSA treatment
Number of subjects: 8
Study: 10625862

Group type: EXPERIMENTAL
Intervention: Antenatal phenobarbital
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 8534744

Group type: EXPERIMENTAL
Intervention: Dialysis solution at a sodium concentration of 126 mEq/L (low sodium)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dialysis solution at a sodium concentration of 132 mEq/L (normal sodium)
Number of subjects: 10
Study: 2014078

Group type: EXPERIMENTAL
Intervention: Amnioinfusion with warmed saline solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Room-temperature saline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 6517242

Group type: EXPERIMENTAL
Intervention: Amezinium methylsulfate 5 mg i.v. given if blood pressure dropped greater than 20 mmHg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study: 30892641

Group type: EXPERIMENTAL
Intervention: Online tailored intervention (n = 63)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Online health education comparison program (n = 62)
Number of subjects: 125
Study: 29253244

Group type: EXPERIMENTAL
Intervention: Automatic lancet
Number of subjects: 70

Group type: COMPARATOR
Intervention: Manual lancet
Number of subjects: 70